DIA Community Sessions
Content Hubs and Community Round Table Discussions are designed to encourage thought-sharing and collaboration with members of DIA Communities.
-
Content Hubs
Have 30 minutes? Join in on a conversation and come away with new perspectives!
This non-traditional learning/networking hybrid is specifically designed for small groups to connect with others that share the same interests. Interact with community leaders and have meaningful discussions to gain rapid insight in a subject of value.
Agenda
Monday, June 20
- #104 CH: What Do Patients Want From Digital Solutions? Considerations for Access, Self Determination of Their Data and Portability
- #122 CH: Transgender and Non-Binary Patients’ Inclusivity in Clinical Research: How Far Have We Come and Where Are We Going Next?
- #123 CH: Mastering the Science of Medical Writing Communications
Tuesday, June 21
- #237.1 CH: Emerging Editorial Policies, Researcher and Author Standards in Promoting Diversity, Inclusion, and Equity in Cancer Research
- #237.2 CH: Location, Location, Location: Building the Next Generation of Community-Based Clinical Trial Site Networks
- #261 CH: How Drug Development Will Change Post-COVID
- #262 CH: Mentoring 101
Wednesday, June 22
- #336 CH: Reviewing FDA's Draft Guidance on PROs in Oncology Trials: How This Affects Future Measurement Strategy and Study Designs
- #360 CH: Considerations for Establishing Meaningful Change for Digital Endpoints Derived from DHT Drug Development Tools
- #361 CH: Separating the AI Hype from Reality: A Primer on NLP (Natural Language Processing)
Thursday, June 23
-
Community Round Table Discussions
DIA Community members will host round table discussions inspired by sessions from within the DIA 2022 program agenda. Community Round Table Discussions are designed to carry learning and debate from sessions to real-life application and discussion. Many of the discussions will include Session Chairs and speakers.
Agenda
Monday, June 20
Tuesday, June 21
- #236 RT: Round Table Discussion: FDA Update on the Upcoming PDUFA VII Data and Technology Commitment
- #237 RT: Round Table Discussion: Individualized Therapeutics: Walking the Line Between Research and Treatment
- #256 RT: Round Table Discussion: Technology-Enabled Clinical Trials Using Electronic Health Record (EHR)-Derived Real-World Data: Opportunities and Limitations
- #257 RT: Round Table Discussion: Enhancing Interactions Among Stakeholders to Advance Patient-Focused Drug Development: Landscape of Current Activities
Wednesday, June 22
- #334 RT: Round Table Discussion: The Value of Medical Writing: The Regulator's Perspective, Development of Professional Medical Writers as Successful Leaders
- #335 RT: Round Table Discussion: Value of Patient Experience Data in Healthcare Decision-Making
- #355 RT: Round Table Discussion: Mission-Driven Research Partners: How Patient Advocacy Organizations Can Help Advance Your Therapeutic R&D Programs
- #356 RT: Round Table Discussion: Planning for the Worst: Approaches for Drug Shortage Avoidance
Thursday, June 23